Target intelligence / Profile preview

Porin A outer-membrane protein (PorA)

Target
PorA
Molecular classification
Outer membrane protein, Porin, Beta-barrel protein
01

Overview

Porin A (PorA) is a major outer membrane protein of Neisseria meningitidis, functioning as a cation-selective pore that facilitates the passive diffusion of small hydrophilic molecules across the bacterial outer membrane [1]. Structurally, it is a 16-stranded beta-barrel protein characterized by eight extracellular loops, with loops 1 and 4 being highly variable and serving as the primary targets for neutralizing antibodies [2]. In Neisseria meningitidis serogroup B, PorA is a significant therapeutic target because it induces a robust serum bactericidal antibody response, which is the established correlate of protection against invasive meningococcal disease [3]. Despite its immunogenicity, the high sequence diversity of the PorA loops poses a significant challenge for vaccine development, as immunity is often restricted to specific strains [4]. PorA is a central component of outer membrane vesicle (OMV) vaccines and is included in the multicomponent vaccine Bexsero to provide protection against specific serogroup B strains [5]. Its role in bacterial fitness and its accessibility on the cell surface make it a focal point for both diagnostic subtyping and preventative immunotherapy [1, 3]. Citations: [1] UniProt (P05022); [2] Massari et al. (2003), The Role of Porins in Neisseria meningitidis Pathogenicity; [3] Holst et al. (2009), Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis; [4] Sacchi et al. (1998), Sequence diversity of PorA from Neisseria meningitidis; [5] Gossger et al. (2012), Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine.

Other names
PorAClass 1 outer membrane proteinPorin AMajor outer membrane protein P1
02

Mechanism of action

Induction of host serum bactericidal antibodies that facilitate complement-mediated killing of the pathogen [3].

03

Biological functions

Passive diffusionIon transportImmune response
04

Disease associations

InfectionMeningitisSepsis
05

Safety considerations

Antigenic variationStrain-specific protectionImmune escape
06

Interacting drugs

Meningococcal Group B Vaccine (Bexsero)

2 more in the full profile.

07

Biomarkers

Serum bactericidal assay (SBA) titerPorA serosubtype

Beyond the preview

Go deeper on Porin A outer-membrane protein (PorA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porin A outer-membrane protein (PorA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call